µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º GwVSRI:[N
76*5/J-
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ !=c&U.B
KIUa
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) (Sg52zv
$r=Ud >
1. ICAM-1 d6k`=Hlg
G?6[K&w
2. interleukin 12(IL-12) ojH-;|f
i;>Hy|
3. tumor infiltrating lymphocyte .sDVBT'%
3E361?ubM
4. TCR/CD3 complex x~tG[Y2F?
k iCg+@nT
5. hematopoietin receptor family LJMw-#61sj
1vQj` F
6. individual idiotype(IdI) vx_v/pD
RSY{IY
7. integrin JtU/%s
F+S;u=CKx
8. colony-stimulatory factor (CSF) ukr
a)>Y[|
pr[[)[]/
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© M+ gYKPP
}cE,&n
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? *r+i=i8{
|T9p#) ec2
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ xF_ Y7rw1w
3L4lk8Dd
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ6;GL>
))'
@qH<4`y.^
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ xgt dmv%
^6ZA2-f/<8
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) rj*4ZA
?
?iUAzM8
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ %?C{0(Z{
JF_\A)<ki
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) <vA^%D<\~
lB
L;aTzo
3. immunoglobulin superfamily (IgSF) 1z$;>+g<
rBkf @
4. selectin lyx
p:
VD.p"F(]
5. anti-idiotypic antibody (¦ÁId) q0w5ADd
%"DEgIP
6. major histocompatibility complex(MHC) zie])_8|h
NJ7N*
7. immunotolerance 2[Q*?N
>u~ [{(d ,
8. biological reponse modifier(BRM) rGRxofi.
wr8n*Du
9. immune reponse gene (Ir gene) (ZjIwA9>
F1)Q#ThF\
10. reshaped antibody (or reconstituted antibody) Sy'/%[+goJ
E[6JHBE*r
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© dt)
BMF8
b2H!{a"
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ }vxb, [#
7|T5N[3?l,
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? m^O:k"+ !
r['T.yo
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ ay'=M`uO_
Rmn| "ZK
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? W2yNEiH
"(/|[7D)
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ c$?qN&X_K
nPfVZGt
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? u-pE
;|
|>A1J:
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ @*q\$Eg}2
c"H4/,F
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ *AGC[w}/
E[nW B"pxE
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? =a?l@dI]
|vTirZP
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ p."pI Bd
T
{(6*^g<B
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: qp
/.$ n>:XR
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: 0$}+t
q+
*u
3K8"XZ
̉񧄤 5^GUuFt5m
U&w
Ve$
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© ;r^8In@6
\ zhT1#O
1. CD8 x~j%
I@+dE V`Lf
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) &UbNp8h
+X
cB 5S>
3. immunoglobulin fold(Ig fold) K}`.?6O
G:c)e,pD
4. cadherin (Ca-dependent cell adhesion moleculers) b&HA_G4
2Ev~[Hb.
5. idiotype-anti-idiotypic antibody immune network theory %Ni)^
9d#-;qV
6. HLA class II antigen -AD3Pd|Y[
=6ZZ/+6b
7. complementarity-determining region (CDR) 'Xxt[Jy
KNQX\-=
8. perforin(or pore-forming protein ,PFP) r<UZ\d -
5z5#_*)O
9. high affinity IL-2 receptor y''`73U"
jNaK]
10. artificial active immunization db@i*Bf
.N5}JUj
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© ,Tvk&<!0
w%S\)wjS
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ>y(;k|-$
&]ts*qCEL
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 &Jk0SUk MP
] 8+!
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ vCFMO3
J5*krH2i
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ :JV=
Kt
t*NZ@)>
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ J)x-Yhe
A'c0zWV2
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? ?y>P
q}*(rR9/Br
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ )c^Rc9e/
\v)Dy)Vhg2
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ 3 i Id>
"|{NRIE
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ Yev] Lp
T4]/w|?G
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ ONH!ms(kb
)^qM%k8
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 9y{[@KG
F=7X,hK
1. immunoglobulin gene rearrangement MCZTeYnx
Q>8F&p?R
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors)
GbUw:I
)e d5~ok
3. flow cytometry(FCM) v8Vw.Ce`f
9]< p
4. carrier effect
>v7fR<(%s
Hbu8gqu
5. positive selection of T lymphocytes in thymus 2&MIt(\-
##+|zka!U
6. mouse TH1(Th1) and TH2(Th2) subsets VG0Ty;bV
~b}a|K
7. perforin (pore-forming protein ,PFP) |5oK04<
'3TwrY?-
8. ADCC(antibody-dependent cell-mediated cytotoxicity) /j/,@,lw7z
JL[$B1
9. SH-2(src-homology region 2) %sxLxx_x!
Jmrs@
10. Ab2¦Â (internal image) 3#N'nhUzA
r<VZEbm)
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© nGQc;p5;
%IrR+f+H
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? i[_(0P+Da
5
.m&93P
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? vT/e&8w
.c__<I<G<
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠtpu2e*n-|
G"k.sRKu
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ ?YE'J~0A6
v:\8
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠ<A|X4;
w-iu/|}
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) ` wI$
8^IV`P~2M
ÃâÒßѧרҵ£º Sg%h}]~
EdL2t``
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ /esdtH$=
LTZ8Eu
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? 6jw9p+.
$>JfLSyC
´«È¾²¡Ñ§×¨Òµ£º uzoI*aqk-s
Ky0}phGRu
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ 3Pu8IXW
e{Q;,jsh
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£
q
t(+X
mXY G^}
Ïû»¯×¨Òµ£º ,`Keqfx
kzE<Y
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ `
0$i^,}
qX[{_$^Q
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? zG0]!A
gt(^9t;
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ [vGkr" =
u^O!5 'D%
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 3F?7oMNIh
I4|LD/b
1. Fas(CD95)/FasL aD(3.=[R
bm*.*A]
2. common chain of cytokine receptor oVTXn=cYDp
yhkKakg,)
3 . TCR/CD3 complex 7lx"
X0w*m
hgj ]Jr
4. negaive selection of thymocytes UX2@eyejQ7
S:K$fFcJ
5. artificial active immune s
TVX/Q
qeW.~B!B
6. anti-idiotypic eZoAy[
4]HW!J
7. IgSF p,V%wG
M
zcC:b4
8. Integrin 4(91T
NEUr w/
9. chemokine 2,Aw6h;
Q#X'.](1
10. B7/CD28 xk
S0Ur{!9\#^
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© -e_|^T"
oiIl\#C
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ ny%$BQM=
;"2VU"
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ ]WzeJ"r {3
joDqv,iW8
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ .p]rS
=#
#K`0b$
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ r7sA;Y\
M KX+'p\w
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ sq;!5qK
ie11syhV"
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ l[]cUE
+?W4ac1
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 2~4&4
mlCBstt{
1. B7/CD28 d``wx}#Uk
6uv~.-T<l
2. Th1 subset L+VQtp&"
s_}6#;
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© >&Oql9_
Vhh=GJ
4. antibody affinity maturation #s81k@#X
,NvXpN
5. AP-1 .heU
Ir,
gq;>DY]
6. single chain variable fragment£¨ScFv£© o<iU;15
J^ewG
7. NK cell receptor ]jm:VF]4
utBrH
8. Zinkernagel-Doherty phenomenon b1cVAfUP
4x
q|
9. Ig fold ^e <E/j{~
[>r0
(x&.
10. CD40/CD40L \>pm (gF
v*qbzW`
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© '8\9@wzv
[`
qdpzUp&
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ X[r0$yuE
@y~kQ5k
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ Y I;iG[T,&
aA52Li
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ J{prI;]
K
|%F,n2
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ (DY[OIHI
\.O&-oi
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ /z4c>)fV
0"%dPKi
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ @`C'tfG
/4
DE/SIy?
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ ^}p##7t[
WEe7\bWF
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© jF0"AA
`MuX/[q
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© _Iav2=0Wi
|r Aot2
1.Co-stimulators (or co-stimulating molecules) !|xB>d
q?
f+uyO7
2.NK-kB *0^~@
U
(~zu4^9w
3.Immunoglobulin superfamily f%@~|:G:
=FhP$r*
4.antigen-presenting cell (APC) jL^@;"/XhC
Wy7w zt
5.death domain JOY&YA$U
Oa~ThbX7
6.CCR and CXCR N=<`|I
oC>J{z
7.Lectin (or mitogen) X'PZCg W
d7vPZ_j^z
8.Clusters of differentiation, CD) W<prY
F6[F~^9D
9.B7 family MmjZq
F5
]<=i
10.Cytotoxic T lymphocyte, CTL) jjj<B'zt
{V
QGfN
11.IL-15 and IL-15 receptor (IL-15R) 6[
A\cs
T
\}U{9ELL
12.MHC restriction vw2E$ya
3?*dv14
13.Affinity-chromatography 05FGfnq.8
r$={_M$
14.Cyctosprin A, CsA AuXUD9-
H 1kI+YJ@
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ,w#lUgp
R|\eBnfI
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© H:~p5t
1PwtzH.w
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 nd8<*ru$
_:m70%i
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ _Rii19k
\
=hg^j
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ pKc!sdC
kuH%aM<R
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© dP8qP_77A~
]AY 4bm
ÃâÒßѧרҵ£º ..8t1+S6]
kS-BB[T
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ w"9h_;'C_
{S=<(A@
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ m0bxVV^DK!
plWN
uEW
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ .jQx2O
MeBTc&S<
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ)
Imhk U%
Z3TCi7,m
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) #g6 _)B=S
fF0K].
1. ADCC(antibody dependent cell-mediated cytotoxicity) $Lstq_x+
YdCl
2. »·æß¾úËØ(cyclosporin) ExO#V9DaW
<9pI~\@w
3. KIR(killer cell inhibitory receptor) vX }iA|`#
@sn:%/x _
4. HLDA(human leucocyte differentiation antigen) `?$-T5Rr
AJ/Hw>>$?m
5. Interleukin 18(IL-18) En&7 e
K7&]|^M9
6. ÕûºÏËØ(integrin) l5w^rj
9\!&c<i=
7. Fas/FasL OG<*&V
\*CXXp`
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) )$^xbC#j`3
-`q!mdA2
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) l)$mpMgAD
h's[)
t
10. Th1/Th2 =M
8Mt/P
Q)aoc.f!v
11. »ùÒòÒßÃç(DNAÒßÃç) vltE2mb
+iN!$zF5]
12. chemokines and chemokine receptor 9'p| [?]v
LeN }Q
13. ÃâÒßÄÍÊÜ nycJZ}f:wP
AT
t.}-
14. ¹²´Ì¼¤·Ö×Ó %GjG.11V,_
9Y2u/|!.3
15. ËÀÍö½á¹¹Óò(death domain) $!G|+OuTR
!"phz&E5ah
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) ){GJgk|P
rs4:jS$)
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? # d"M(nt
`ci
P
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦ÓᣠsuQ`a_zJ
L
'
_%zO
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î %zc.b
7y&